Phosphodiesterase 5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review

Humberto K. Laydner; Paulo Oliveira; Carlos Roberto A. Oliveira; Tafadzwa P. Makarawo; Weslley S. Andrade; Matheus Tannus; José Luciano R. Araújo

doi:10.1111/j.1464-410x.2010.09698.x

Phosphodiesterase 5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review

BJU International ◽

10.1111/j.1464-410x.2010.09698.x ◽

2010 ◽

Vol 107 (7) ◽

pp. 1104-1109 ◽

Cited By ~ 29

Author(s):

Humberto K. Laydner ◽

Paulo Oliveira ◽

Carlos Roberto A. Oliveira ◽

Tafadzwa P. Makarawo ◽

Weslley S. Andrade ◽

...

Keyword(s):

Systematic Review ◽

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase 5 ◽

Lower Urinary

Download Full-text

Study of phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

Minerva Urologica e Nefrologica ◽

10.23736/s0393-2249.19.03408-8 ◽

2020 ◽

Vol 72 (1) ◽

Cited By ~ 5

Author(s):

Yi Sun ◽

Bo Peng ◽

Guo-Lin Lei ◽

Qiang Wei ◽

Lu Yang

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase 5 ◽

Lower Urinary

Download Full-text

Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms

BJU International ◽

10.1111/j.1464-410x.2006.06501.x ◽

2006 ◽

Vol 98 (6) ◽

pp. 1259-1263 ◽

Cited By ~ 122

Author(s):

Hanna Tinel ◽

Beatrix Stelte-Ludwig ◽

Joachim Hütter ◽

Peter Sandner

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Clinical Evidence ◽

Prostatic Hyperplasia ◽

Phosphodiesterase 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase 5 ◽

Lower Urinary

Download Full-text

A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

European Urology ◽

10.1016/j.eururo.2012.02.033 ◽

2012 ◽

Vol 61 (5) ◽

pp. 994-1003 ◽

Cited By ~ 189

Author(s):

Mauro Gacci ◽

Giovanni Corona ◽

Matteo Salvi ◽

Linda Vignozzi ◽

Kevin T. McVary ◽

...

Keyword(s):

Systematic Review ◽

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Meta Analysis ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase 5 ◽

Lower Urinary

Download Full-text

Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?

BJU International ◽

10.1111/j.1464-410x.2009.08418.x ◽

2009 ◽

Vol 104 (4) ◽

pp. 511-517 ◽

Cited By ~ 19

Author(s):

Thierry Roumeguère ◽

K. Zouaoui Boudjeltia ◽

Claude Hauzeur ◽

Claude Schulman ◽

Michel Vanhaeverbeek ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase 5 ◽

Chronic Use ◽

Lower Urinary

Download Full-text